The Latest Breaking News from Obesity

Availability of oral pills to treat obesity could expand the booming market for obesity treatments by broadening access and reducing costs, experts said.

U.S. regulators have approved a pill version of the weight-loss drug Wegovy, a boon for drugmaker Novo Nordisk

We never know what demons other people are fighting, even if we think we see their problems from the outside. Those who struggle with obesity often have trouble with their self-esteem, body image, anxiety, and depression. Nowadays, weight loss medications like Ozempic and Mounjaro might make their weight loss journeys…

Researchers found a link between the hormone estrone and breast cancer deaths in postmenopausal women

Wave Life Sciences Ltd. (NASDAQ:WVE) on Monday shared interim data from the lowest therapeutic cohort of the ongoing first-in-human INLIGHT trial evaluating WVE-007, an investigational INHBE GalNAc-siRNA using Wave’s proprietary SpiNA design, for obesity.

They are ‘struggling’ to access support as funding hasn’t kept up with demand

An Ozempic-like drug implant might be available for your pets soon. Okava Pharma's GLP-1 implant pilot for obese cats (MEOW-1) aims to combat feline obesity, with due results in 2026.

Viking Therapeutics Inc (NASDAQ:VKTX) shares are trading higher on Thursday. The clinical-stage biopharmaceutical company seems to be benefitting from wider excitement in the obesity treatment area, as well as recent positive momentum after major clinical trial developments.

Okava Pharmaceuticals, a biopharmaceutical company, has launched a pilot study of a GLP-1 drug for cats with obesity